Chromium(VI) substances are concerned because they can enter the human body through inhalation and, ingestion. Furthermore, long-term exposure can cause serious health problems, like lung and intestinal cancer.
Thus, the Commission asked ECHA to include Cr(VI) substances listed in REACH Annex XIV, except the lead chromates (entries 10, 11 and 12), in the scope of the Annex XV restriction dossier in view of a possible restriction covering these substances in addition to chromium trioxide and chromic acids. Moreover, ECHA has been requested to consider in the restriction proposal other chromium (VI) substances not listed on the Authorisation List, with particular attention to barium chromate (EC number 233-660-5).
The proposed restriction could potentially replace existing authorisation requirements under REACH, ensuring that the risks associated with Cr(VI) substances are effectively controlled once they are no longer subject to REACH authorisation.
ECHA has proposed an EU-wide restriction on Chromium(VI) substances. The proposal aims to prevent up to 17 tonnes of Cr(VI) from being released into the environment and to reduce the harmful effects of these carcinogenic chemicals for both workers and the public. Indeed, this restriction could prevent around 200 cancer cases each year.
Chromium(VI) substances, are used, for example, in formulation of mixtures, functional additives, electroplating, primers and other surface treatment.
Consequently, ECHA proposes to introduce a ban on Cr(VI) substances, except in the following use categories when they meet defined limits for worker exposure and environmental emissions:
ECHA’s scientific Committees for Risk Assessment (RAC) and Socio-Economic Analysis (SEAC) will evaluate the restriction proposal. In their evaluation, they will consider the scientific evidence received during the consultations.
The final decision will be made by the European Commission in collaboration with all EU Member States. Stakeholders have the opportunity to provide information backed by robust evidence during a six-month consultation, which is expected to start on 18 June 2025.
If adopted, the restriction under Annex XVII of REACH is expected to take effect in 2028 and will apply to all uses of these substances in the European Economic Area (EU Member States + Iceland, Liechtenstein, and Norway).
Trace One is paying close attention to the development of the regulatory situation and will keep you updated on any new developments.
For more information, please click on the following link: